Early salvage radiotherapy following radical prostatectomy

European Urology

Volumn 65, Issue 6, 2014, Pages 1034-1043

  Pfister, David ^a   Bolla, Michel ^b   Briganti, Alberto ^c   Carroll, Peter ^d   Cozzarini, Cesare ^e   Joniau, Steven ^f   Van Poppel, Hein ^f   Roach, Mack ^d   Stephenson, Andrew ^g   Wiegel, Thomas ^h   Zelefsky, Michael J ⁱ  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HÔPITAL MICHALLON   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g LERNER RESEARCH INSTITUTE   (United States)

^h UNIVERSITY HOSPITAL ULM   (Germany)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biochemical recurrence free survival; Early salvage radiotherapy; Prostate cancer; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; HUMAN; INFORMATION RETRIEVAL; LYMPH NODE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT OUTCOME; BLOOD; DISEASE FREE SURVIVAL; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; TIME;

DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TIME FACTORS;

EID: 84899584952     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.08.013     Document Type: Review

References (45)

1. J.F. Ward, J.M. Slezak, M.L. Blute, and H. Zincke Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome BJU Int 95 2005 751 756
2. M. Spahn, C. Weiss, and P. Bader et al. Long-term outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivation Urol Int 84 2010 164 173
3. C.J. Kane, R. Im, C.L. Amling SEARCH Database Study Group Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database Urology 76 2010 695 700
4. A. Briganti, T. Wiegel, and S. Joniau et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis Eur Urol 62 2012 472 487
5. M. Bolla, H. van Poppel, L. Collette European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
6. T. Wiegel, D. Bottke, and U. Steiner et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
7. I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
8. I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
9. K. Zakeri, B.S. Rose, S. Gulaya, A.V. D'Amico, and L.K. Mell Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794 Contemp Clin Trials 34 2013 74 79
10. T. Daly, B.E. Hickey, M. Lehman, D.P. Francis, and A.M. See Adjuvant radiotherapy following radical prostatectomy for prostate cancer Cochrane Database Syst Rev 2011 CD007234
11. P. Ost, B. De Troyer, V. Fonteyne, W. Oosterlinck, and G. De Meerleer A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1316 1322
12. E.J. Trabulsi, R.K. Valicenti, and A.L. Hanlon et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer Urology 72 2008 1298 1302 discussion 302-4
13. R.K. Valicenti, L.G. Gomella, and M. Ismail et al. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis Int J Radiat Oncol Biol Phys 45 1999 53 58
14. C. Catton, M. Gospodarowicz, and P. Warde et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate Radiother Oncol 59 2001 51 60
15. A.J. Stephenson, S. Shariat, and M. Zelefsky et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
16. A.J. Stephenson, P.T. Scardino, and M.W. Kattan et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
17. A. Siegmann, D. Bottke, and J. Faehndrich et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study Strahlenther Onkol 187 2011 467 472
18. F. Wenz, T. Martin, and D. Böhmer et al. The German S3 guideline prostate cancer: aspects for the radiation oncologist Strahlenther Onkol 186 2010 531 534
19. T. Martin, F. Wenz, and D. Böhmer et al. Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy [in German] Urologe A 49 2010 216 220
20. L. Quero, P. Mongiat-Artus, V. Ravery, C. Maylin, F. Desgrandchamps, and C. Hennequin Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience BMC Cancer 8 2008 26
21. N. Tomita, T. Kodaira, and K. Furutani et al. Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy J Cancer Res Clin Oncol 135 2009 1561 1567
22. C.M. Hugen, A.J. Polcari, M.L. Quek, R.P. Garza, M.P. Fitzgerald, and R.C. Flanigan Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: validation of the Stephenson nomogram World J Urol 28 2010 741 744
23. J.R. Bernard, S.J. Buskirk, and M.G. Heckman et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
24. S.L. Liauw, W.S. Webster, D.A. Pistenmaa, and C.G. Roehrborn Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience Urology 61 2003 1204 1210
25. A. Goenka, J.M. Magsanoc, and X. Pei et al. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment Int J Radiat Oncol Biol Phys 84 2012 112 118
26. A.J. Stephenson, P.T. Scardino, F.J. Bianco, and J.A. Eastham Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy Curr Treat Options Oncol 5 2004 357 365
27. E. Hudson, H. Kynaston, and M. Varma et al. Radiotherapy after radical prostatectomy for adenocarcinoma of the prostate: a UK institutional experience and review of published studies Clin Oncol (R Coll Radiol) 20 2008 353 357
28. R. Umezawa, H. Ariga, and Y. Ogawa et al. Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml Radiat Oncol 6 2011 150
29. A. Terai, Y. Matsui, K. Yoshimura, Y. Arai, and Y. Dodo Salvage radiotherapy for biochemical recurrence after radical prostatectomy BJU Int 96 2005 1009 1013
30. A. Siegmann, D. Bottke, and J. Faehndrich et al. Salvage radiotherapy after prostatectomy - what is the best time to treat? Radiother Oncol 103 2012 239 243
31. A. Goenka, J.M. Magsanoc, and X. Pei et al. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy Eur Urol 60 2011 1142 1148
32. R.G. Cremers, E.N. van Lin, and W.L. Gerrits et al. Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy Radiother Oncol 97 2010 467 473
33. J.P. Brooks, P.S. Albert, R.B. Wilder, D.A. Gant, D.G. McLeod, and M.M. Poggi Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors J Urol 174 2005 2204 2208 discussion 2208
34. O.K. Macdonald, S.E. Schild, and S.A. Vora et al. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy J Urol 170 2003 1833 1837
35. J.L. Peterson, S.J. Buskirk, and M.G. Heckman et al. Late toxicity after postprostatectomy salvage radiation therapy Radiother Oncol 93 2009 203 206
36. C. Cozzarini, C. Fiotino, and L.F. DaPozzo et al. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients Int J Radiation Oncology Biol Phys 82 2012 191 199
37. P. Ost, N. Lumen, and A.S. Goessaert et al. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results Eur Urol 60 2011 842 849
38. S.A. Boorjian, R.J. Karnes, P.L. Crispen, L.J. Rangel, E.J. Bergstralh, and M.L. Blute Radiation therapy after radical prostatectomy: impact on metastasis and survival J Urol 182 2009 2708 2715
39. B. Trock, M. Han, and S. Freedland et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769
40. C.R. King The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 84 2012 104 111
41. A. Zurlo, L. Collette, and G. van Tienhoven et al. Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863 Eur Urol 42 2002 125 132
42. F. Ataman, A. Zurlo, and X. Artignan et al. Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863 Eur J Cancer 40 2004 1674 1681
43. M. Bolla, H. van Poppel, B. Tombal European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
44. A. Briganti, S. Joniau, and P. Gontero et al. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer Eur Urol 61 2012 584 592
45. A.J. Stephenson, M. Bolla, and A. Briganti et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy Eur Urol 61 2012 443 451